About Us Research Groups Publications Rappaport Prize Conferences News Links Contact Us  

Lior Gepstein, MD, PhD

Professor of Physiology

MD, 1996 - Technion, Israel
PhD, 1999 - Technion, Israel

Using pluripotent stem cells to investigate cardiovascular physiology and pathology

My research group applies emerging pluripotent stem cell technologies to cardiovascular studies. Current research topics include: 1, developing novel cell therapy and tissue engineering strategies for treatment of cardiac disorders (heart failure and cardiac arrhythmias); 2, drug screening and discovery; and 3, disease modeling of inherited cardiac disorders. In the case of cardiac disease modeling, human induced pluripotent stem cells (hiPSCs) are established from patients with different types of inherited cardiomyopathies (such as dilated, hypertrophic and metabolic cardiomyopathies) or arrhythmogenic syndromes (long QT syndrome and catecholaminergic polymorphic ventricular tachycardia - CPVT). These disease states can result in sudden cardiac death in otherwise healthy individuals. The patient-specific hiPSCs lines are coaxed to differentiate into cardiomyocytes, which then are characterized using detailed molecular, structural and functional analyses. These studies are expected to provide new mechanistic insights into inherited cardiac disorders, to allow optimization of patient-specific therapies (personalized medicine), and to facilitate development of new therapies.

 

Figure Legend:

Human heart cell generated from induced pluripotent stem cells.

 

Representative Publications

Itzhaki I, Maizels L, Huber I, Gepstein A, Arbel A, Caspi O, Miller L, Belhassen B, Nof E, Glikson M, Gepstein L. 2012. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human induced pluripotent stem cells. J Am Coll Cardiol. 60, 990-1000.

 

Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel A, Hammerman H, Boulos M, Gepstein L. 2011. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 471, 225-229.

 

Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L. 2009. Cardiomyocyte differentiation of human induced pluripotents stem cells. Circulation. 120, 1513-1523.

           

 

Email: mdlior@tx.technion.ac.il
Related Links
Human heart cell generated from induced pluripotent stem cells
Human heart cell generated from induced pluripotent stem cells
Show Publications
By Year
By Author
Publication Search
Keyword (s)
Topic
Date
 
Related Links

BioRap Technologies Ltd.

Technion

Faculty of Medicine

Important Events

The Nobel Prize in Chemistry 2004

Professors Avram Hershko and Aaron Ciechanover - winners of the 2004 Nobel Prize in Chemistry.
  1 Efron Street, P.O. Box 9697, Haifa 31096, Israel,
Tel: 972-4-829-5365, Fax: 972-4-855-2296, Email: edelman@tx.technion.ac.il
2006 Rappaport Institute. All Rights Reserved. Created by Catom web design